Novo's FDA voucher victory; biotech's rigid glass ceiling [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Some of the biggest news and trends captured in PharmaVoice's newsletter this week. Sign up here to receive the newsletter daily. Novo scores an FDA win Drugs in the FDA's new review voucher program have been on a roll. Novo Nordisk scored the program's fourth approval last week when the FDA OK'd its higher-dose version of Wegovy. But the Commissioner's National Priority Voucher program has also picked up plenty of detractors. Unveiled last year with the aim of shrinking review timelines to a few months for drugs in the country's “national interests,” the details of the program and who wins a voucher remain “ shrouded in secrecy ,” according to one lawmaker. With Congressional pressure mounting on the FDA to provide answers, the agency will host a public meeting on the program in June. The voucher program is one of several regulatory factors causing unpredictability through the industry, including orphan drugs. This week, we looked at the outlook for the orphan market and the
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed [MSNBC.com]MSNBC.com
- EU regulator backs Sanofi's injectable version of blood cancer drug [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myelomaGlobeNewswire
- Sanofi (SNY) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 3/24/26 - Form 6-K
- 3/10/26 - Form 6-K
- 3/4/26 - Form 6-K
- SNY's page on the SEC website